Spots Global Cancer Trial Database for ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
Official Title: Use of Natural Language Processing ChatBot and Automated Continuous Activity Monitoring Via Mobile Phones for Early Detection and Management of Symptoms in Patients Undergoing Cancer Treatment
Study ID: NCT05318027
Interventions
Study Description
Brief Summary: Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact Details
Name: Arun Goel, MD
Affiliation: University of Pennsylvania
Role: PRINCIPAL_INVESTIGATOR
Name: Kristine Kim, MD
Affiliation: University of Pennsylvania
Role: PRINCIPAL_INVESTIGATOR
Name: Nishant Shah, MD
Affiliation: University of Pennsylvania
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
